Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Equivalence of Calcium Gluconate and Chloride in Parturients
NCT05973747Phase 1Completed
- Sponsor
- Stanford University
- Start
- Aug 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of calcium gluconate in postpartum hemorrhage (PPH) and hypocalcemia (2 arms), sponsored by Stanford University. Primary endpoints: Bioequivalent ratio of calcium gluconate to calcium chloride at 60 minutes, Clearance from first to second compartment at 60 minutes and 1 more. Started Aug 2023; status: completed.
02
Drugs
calcium gluconate
03
Conditions
postpartum hemorrhage (PPH)hypocalcemia
Beyond the preview
Go deeper on NCT05973747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05973747.